1. Choi NK, Park BJ. Strategy for establishing an effective Korean drug utilization review system. J Korean Med Assoc. 2010; 53:1130–1138.
Article
2. Robb MA, Racoosin JA, Sherman RE, Gross TP, Ball R, Reichman ME, Midthun K, Woodcock J. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Pharmacoepidemiol Drug Saf. 2012; 21:Suppl 1. 9–11.
Article
3. Blake KV, Prilla S, Accadebled S, Guimier M, Biscaro M, Persson I, Arlett P, Blackburn S, Fitt H. European Medicines Agency review of post-authorisation studies with implications for the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. Pharmacoepidemiol Drug Saf. 2011; 20:1021–1029.
Article
4. Personal Information Protection Act, Law No. 10465. 2011. 03. 29.
5. Bioethics and Biosafety Act, Law No. 11250. 2012. 02. 01.
6. Kaiser J. Patient records: privacy rule creates bottleneck for U.S. biomedical researchers. Science. 2004; 305:168–169.
Article
7. Ness RB. Joint Policy Committee, Societies of Epidemiology. Influence of the HIPAA Privacy Rule on health research. JAMA. 2007; 298:2164–2170.
Article
8. National Evidence-based Healthcare Collaborating Agency. A round-table conference for utilizing personal health information while protecting its privacy and integrity. Seoul: National Evidence-based Healthcare Collaborating Agency;2011.
9. Lee KM, Ahn BC. A study on the concept of public interest in Korea: focus on the content analysis of law related to public interest. Korean Policy Sci Rev. 2011; 15:1–27.
10. National Evidence-based Healthcare Collaborating Agency. A foundational study for the system establishment to link data sources in healthcare. Seoul: National Evidence-based Healthcare Collaborating Agency;2010.
11. Act on the Management of Public Institutions, Law No. 8258. 2007. 01. 19.
12. Lee LM, Gostin LO. Ethical collection, storage, and use of public health data: a proposal for a national privacy protection. JAMA. 2009; 302:82–84.
Article
13. Fairchild AL, Gable L, Gostin LO, Bayer R, Sweeney P, Janssen RS. Public goods, private data: HIV and the history, ethics, and uses of identifiable public health information. Public Health Rep. 2007; 122:Suppl 1. 7–15.
Article
14. Sutrop M. Changing ethical frameworks: from individual rights to the common good? Camb Q Healthc Ethics. 2011; 20:533–545.
Article
15. US National Institute of Health. ClinicalTrials.gov [Internet]. Bethesda: US National Institute of Health;cited 2013 Jun 30. Available from:
http://www.clinicaltrials.gov/.
16. World Health Organization. International Clinical Trials Registry Platform (ICTRP) [Internet]. Geneva: World Health Organization;cited 2013 Jun 30. Available from:
http://www.who.int/ictrp/en/.
17. Korea National Institute of Health. The Clinical Research Information Service (CRIS) [Internet]. Cheongwon: Korea National Institute of Health;cited Jun 30. Available from:
http://cris.nih.go.kr/.
18. Act on the Activation and Usage of Public Databases, Law No. 11956. 2013. 07. 30.